Uses smartwatches to track spasticity in people with multiple sclerosis
Studies whether wearable smartwatch measures can track spasticity in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Smart Monitoring Assessing Spasticity-related Health
Key facts
- Where
- Düsseldorf, GermanySee the site
Where in Germany
- Medical Faculty, Heinrich-Heine-UniversityDüsseldorf, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Heinrich-Heine University, Duesseldorf
- Trial code
- NCT06937723
- Record updated
- 22 April 2025
- Original description
This observational study seeks to investigate the underlying of spasticity in patients with multiple sclerosis (MS) by employing multimodal monitoring techniques. By integrating digital biomarkers alongside clinical monitoring, the investigators aim to evaluate whether digital measurements are suitable for monitoring spasticity-related everyday limitations and to compare them with established clinical scores, blood analyses and questionnaires including sores on quality of life, sleep quality or activities of daily living.Read full original descriptionShow less
Smart Monitoring Assessing Spasticity-related Health - A Prospective Multiple Sclerosis Study With Wearables
This observational study seeks to investigate the underlying of spasticity in patients with multiple sclerosis (MS) by employing multimodal monitoring techniques. By integrating digital biomarkers alongside clinical monitoring, the investigators aim to evaluate whether digital measurements are suitable for monitoring spasticity-related everyday limitations and to compare them with established clinical scores, blood analyses and questionnaires including sores on quality of life, sleep quality or activities of daily living.
Inclusion: Patients must meet all the following criteria to be eligible to participate in the study:; ≥ 18 years of age; Diagnosis of multiple sclerosis according to the McDonald criteria of 2017; Presence of spasticity that requires medical treatment from a medical point of view; own and use a smartphone with Android 8.1 (or higher version) or iOS 12.3 (or higher version); Able to operate a smartphone.
Exclusion: Any comorbidity that leads to impaired understanding or successful completion of the study, such as (but not limited to) psychiatric comorbidities or dementia. The decision will be made at the discretion of the investigators; Missing informed consent; Lack of declaration of consent; Unwillingness or inability to use the smartphone app.